Competitor Analysis: Interleukin-4/-13 (IL-4/-13) Inhibitors or Receptor Antagonists
Competitor Analysis: Interleukin-4/-13 (IL-4/-13) Inhibitors or Receptor Antagonists
The Competitive Intelligence report about inhibitors of interleukin-4 (IL-4) and/or IL-13 and antagonists of the IL-4 or IL-13 receptor provides a competitor analysis of novel antibody molecules for treatment of inflammatory and autoimmune diseases such as atopic dermatitis, asthma, sinusitis, esophagitis or idiopathic pulmonary fibrosis as of September 2015. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report provides a compilation of active R&D projects with specific IL-4 or IL-13 receptor antagonists and with specific IL-13 or dual target IL-4/13 inhibitors for treatment of immunologic diseases. Competitor projects are listed in a tabular format providing information on:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
The Competitive Intelligence report about inhibitors of interleukin-4 (IL-4) and/or IL-13 and antagonists of the IL-4 or IL-13 receptor provides a competitor analysis of novel antibody molecules for treatment of inflammatory and autoimmune diseases such as atopic dermatitis, asthma, sinusitis, esophagitis or idiopathic pulmonary fibrosis as of September 2015. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report provides a compilation of active R&D projects with specific IL-4 or IL-13 receptor antagonists and with specific IL-13 or dual target IL-4/13 inhibitors for treatment of immunologic diseases. Competitor projects are listed in a tabular format providing information on:
- Drug Codes
- Target/Mechanism of Action
- Class of Compound
- Company
- Product Category
- Indication,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
IL-4 Receptor Antagonists
IL-13 Inhibitors & IL-13 Receptor Antagonists
Dual IL-4 & IL-13 Inhibitors
Corporate IL-4/-13 Inhibitor or Receptor Antagonist R&D Portfolios
IL-13 Inhibitors & IL-13 Receptor Antagonists
Dual IL-4 & IL-13 Inhibitors
Corporate IL-4/-13 Inhibitor or Receptor Antagonist R&D Portfolios
